Topics: Advanced Wound Care
SmartTRAK reports that Q219 performance in the OrthoBio market was strong, up 6% YoY, exceeding SmartTRAK expectations. As expected, Medtronic was the overall OrthoBio market leader, followed by DePuy Synthes and Stryker. Overall, all OrthoBio technologies grew year-over-year except for Spinal Constructs, Soft Tissue Augmentation and Synthetic Cartilage. Although the Spine market has stabilized, Spinal Constructs continues to slowly lose share due to...
The WW Market for Foot & Ankle Fixation was up +2.0%, as reported, during Q219, although down sequentially due to tough YoY comps. The US Foot & Ankle Fixation market also experienced a sequential decline in growth. The historically strong segment faced extremely tough YoY comparisons along with no new product launches to spur growth. H119 US growth of...
Ahead of the Orthopedic Trauma Association (OTA) meeting, see what SmartTRAK’s Senior Analyst for Trauma & Extremities, Natasha Weeks, has to say about the latest trends in Trauma.Natasha recently wrote a fascinating and informative article, " Trauma: Top Trends to Watch in 2019 and Beyond", in which she took a look back at 2018 and identified continuing and emerging trauma trends in the market that are likely to shape the landscape in 2019 and beyond. If you would like to download the article and discover SmartTRAK’s predictions for the top trauma market trends to watch, just click the button below.
As reported in SmartTRAK’s Financial Dashboard, every manufacturer in the US Hemostats and Sealants market, except Ethicon, experienced revenue growth in Q219. Leading the way was Baxter, as it capitalized on Ethicon’s supply problems with Surgiflo. Cryolife and Becton Dickinson (BD) both posted strong gains. Ethicon still continued to dominate the overall US Hemostat and Sealants market, with a 40.7% share, down from 48.6% share in Q119. Most of this share shifted to Baxter as the Company continues to chip away at...
Topics: Surgical Matrices
Nate Greenlee has joined the SmartTRAK team as Product Director. Nate has 20+ years experience as a startup founder and executive. Before joining SmartTRAK, Nate helped launch software, big data and new space companies, spanning the financing gamut from bootstrapped, angel-funded and VC funded companies, including Space Adventures, LTD., which has currently sold over $500 Million in Private Space Flights to the International Space Station.
Topics: Your SmartTRAK News
With two earnings seasons of 2019 behind us, US Total Joints Market growth of 1.7% for H119, as modeled by SmartTRAK Financial Dashboard, is trending below SmartTRAK projections of 2.6% growth for FY19. This trend is not surprising considering the heightened seasonality we’ve seen over the last few years in H2 due to high patient deductibles. US Total Joints Market growth strengthened slightly to 1.8% for Q219 compared to 1.6% in Q1 driven by...
Topics: Orthopedics-Total Joints
Rachel Dolan is SmartTRAK's new Corporate Enterprise Solutions Manager. Rachel has 5+ years in the sports medicine and medical device industries, most recently serving as Account Manager for Stryker Medical working with all organizational levels of hospital customers.Meet Rachel Dolan:
- What is your role with SmartTRAK? I am the Corporate Enterprise Solutions Account Manager. I’m responsible for managing and developing client accounts to initiate and maintain favorable relationship with clients.
Topics: Your SmartTRAK News
Join SmartTRAK for breakfast and an Executive Panel on “Advanced Technologies: Shifts in the Spine Landscape” at McCormick Place in Chicago, IL on Sept 26th. A panel of experts will be on hand to discuss the latest in advanced technologies, interbody devices, materials and design, and the impact these changes pose from an FDA regulatory standpoint.
Date: Thursday, September 26th, 2019
Location: Hyatt Regency McCormick Place, Chicago, IL
Room: Jackson Park C&D